Endopath Xcel
Payments companies reported to CMS as associated with Endopath Xcel. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Endopath Xcel, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Endopath Xcel
These are the largest totals companies reported as associated with Endopath Xcel. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Craig Morgenthal | Jacksonville, FL | Surgery | $9,000.00 |
| Onur Kutlu | Miami, FL | Surgery | $3,030.00 |
| Ildiko Lingvay | Dallas, TX | Endocrinology, Diabetes & Metabolism | $3,000.00 |
| Marina Kurian | New York, NY | Surgery | $2,777.50 |
| David Cummings | Seattle, WA | $1,110.00 | |
| Thomas Sonnanstine | Columbus, OH | Surgery | $450.00 |
| Alan Schlaerth | Arcadia, CA | Gynecologic Oncology | $141.00 |
| John Diaz | Miami, FL | Gynecologic Oncology | $134.16 |
| Josiah Wagler | Oklahoma City, OK | Surgery | $133.54 |
| Esber Nabeeh Shea Samara | Oklahoma City, OK | Urology | $133.54 |
Prescribed Endopath Xcel?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.